Sirolimus as a possible treatment in cleavage-resistant RIPK1-induced autoinflammatory syndrome

J Allergy Clin Immunol Pract. 2024 Nov 16:S2213-2198(24)01167-X. doi: 10.1016/j.jaip.2024.11.003. Online ahead of print.
No abstract available